JP2010505556A - 脳脊髄液精製システム - Google Patents
脳脊髄液精製システム Download PDFInfo
- Publication number
- JP2010505556A JP2010505556A JP2009531646A JP2009531646A JP2010505556A JP 2010505556 A JP2010505556 A JP 2010505556A JP 2009531646 A JP2009531646 A JP 2009531646A JP 2009531646 A JP2009531646 A JP 2009531646A JP 2010505556 A JP2010505556 A JP 2010505556A
- Authority
- JP
- Japan
- Prior art keywords
- csf
- patient
- conditioning
- location
- space
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000001175 cerebrospinal fluid Anatomy 0.000 title claims abstract description 426
- 238000000746 purification Methods 0.000 title description 18
- 238000000034 method Methods 0.000 claims abstract description 129
- 230000003750 conditioning effect Effects 0.000 claims abstract description 75
- 230000007717 exclusion Effects 0.000 claims abstract description 19
- 210000000278 spinal cord Anatomy 0.000 claims description 56
- 230000001143 conditioned effect Effects 0.000 claims description 35
- 208000024891 symptom Diseases 0.000 claims description 32
- 210000004556 brain Anatomy 0.000 claims description 30
- 238000002156 mixing Methods 0.000 claims description 26
- 230000002757 inflammatory effect Effects 0.000 claims description 25
- 235000018102 proteins Nutrition 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 24
- 108090000623 proteins and genes Proteins 0.000 claims description 24
- 201000006417 multiple sclerosis Diseases 0.000 claims description 22
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 20
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 18
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 18
- 208000006011 Stroke Diseases 0.000 claims description 16
- 238000013459 approach Methods 0.000 claims description 16
- 208000024827 Alzheimer disease Diseases 0.000 claims description 14
- 208000035895 Guillain-Barré syndrome Diseases 0.000 claims description 13
- 206010049567 Miller Fisher syndrome Diseases 0.000 claims description 13
- 108010021188 Superoxide Dismutase-1 Proteins 0.000 claims description 12
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 12
- 210000004027 cell Anatomy 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 12
- 108010074328 Interferon-gamma Proteins 0.000 claims description 11
- 102000008070 Interferon-gamma Human genes 0.000 claims description 11
- 108010002350 Interleukin-2 Proteins 0.000 claims description 11
- 108090001005 Interleukin-6 Proteins 0.000 claims description 11
- 208000018737 Parkinson disease Diseases 0.000 claims description 11
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 11
- 229960003130 interferon gamma Drugs 0.000 claims description 11
- 206010014599 encephalitis Diseases 0.000 claims description 10
- 210000002330 subarachnoid space Anatomy 0.000 claims description 10
- 102000013498 tau Proteins Human genes 0.000 claims description 10
- 108010026424 tau Proteins Proteins 0.000 claims description 10
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 claims description 9
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 claims description 9
- 238000005349 anion exchange Methods 0.000 claims description 9
- 238000005341 cation exchange Methods 0.000 claims description 9
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 8
- 108050009340 Endothelin Proteins 0.000 claims description 8
- 102000002045 Endothelin Human genes 0.000 claims description 8
- 102000000588 Interleukin-2 Human genes 0.000 claims description 8
- 102000004889 Interleukin-6 Human genes 0.000 claims description 8
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 claims description 8
- 230000002502 anti-myelin effect Effects 0.000 claims description 6
- 208000001286 intracranial vasospasm Diseases 0.000 claims description 6
- 102000013455 Amyloid beta-Peptides Human genes 0.000 claims description 5
- 108010090849 Amyloid beta-Peptides Proteins 0.000 claims description 5
- 108090000185 alpha-Synuclein Proteins 0.000 claims description 5
- 210000003743 erythrocyte Anatomy 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- 239000002158 endotoxin Substances 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 101000941598 Homo sapiens Complement C5 Proteins 0.000 claims description 3
- 230000002572 peristaltic effect Effects 0.000 claims description 3
- 102100031506 Complement C5 Human genes 0.000 claims description 2
- 108010054147 Hemoglobins Proteins 0.000 claims description 2
- 102000001554 Hemoglobins Human genes 0.000 claims description 2
- 108010064719 Oxyhemoglobins Proteins 0.000 claims description 2
- 230000014759 maintenance of location Effects 0.000 claims description 2
- 102100038836 Superoxide dismutase [Cu-Zn] Human genes 0.000 claims 2
- 102100026882 Alpha-synuclein Human genes 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 35
- 201000010099 disease Diseases 0.000 abstract description 32
- 150000001875 compounds Chemical class 0.000 abstract description 20
- 239000003814 drug Substances 0.000 abstract description 12
- 229940124597 therapeutic agent Drugs 0.000 abstract description 8
- 239000003053 toxin Substances 0.000 abstract description 7
- 231100000765 toxin Toxicity 0.000 abstract description 7
- 108700012359 toxins Proteins 0.000 abstract description 7
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 238000004587 chromatography analysis Methods 0.000 abstract description 3
- 238000012377 drug delivery Methods 0.000 abstract description 3
- 230000007170 pathology Effects 0.000 abstract description 2
- 210000003625 skull Anatomy 0.000 description 23
- 210000003169 central nervous system Anatomy 0.000 description 18
- 230000009977 dual effect Effects 0.000 description 18
- 238000011282 treatment Methods 0.000 description 18
- 238000012545 processing Methods 0.000 description 15
- 239000012530 fluid Substances 0.000 description 13
- 238000009169 immunotherapy Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 208000020431 spinal cord injury Diseases 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 230000002861 ventricular Effects 0.000 description 11
- 102000008221 Superoxide Dismutase-1 Human genes 0.000 description 10
- 208000030886 Traumatic Brain injury Diseases 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 230000009529 traumatic brain injury Effects 0.000 description 10
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 9
- 238000013461 design Methods 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 230000009885 systemic effect Effects 0.000 description 9
- 210000000653 nervous system Anatomy 0.000 description 8
- 229910001000 nickel titanium Inorganic materials 0.000 description 8
- 231100000331 toxic Toxicity 0.000 description 8
- 230000002588 toxic effect Effects 0.000 description 8
- 230000008499 blood brain barrier function Effects 0.000 description 7
- 210000001218 blood-brain barrier Anatomy 0.000 description 7
- 230000002631 hypothermal effect Effects 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 229930195712 glutamate Natural products 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 102400000686 Endothelin-1 Human genes 0.000 description 5
- 101800004490 Endothelin-1 Proteins 0.000 description 5
- 208000012902 Nervous system disease Diseases 0.000 description 5
- 208000025966 Neurological disease Diseases 0.000 description 5
- 101710120037 Toxin CcdB Proteins 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 210000002987 choroid plexus Anatomy 0.000 description 5
- 210000003722 extracellular fluid Anatomy 0.000 description 5
- 210000004705 lumbosacral region Anatomy 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000000115 thoracic cavity Anatomy 0.000 description 5
- JVJFIQYAHPMBBX-UHFFFAOYSA-N 4-hydroxynonenal Chemical compound CCCCCC(O)C=CC=O JVJFIQYAHPMBBX-UHFFFAOYSA-N 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 102000003802 alpha-Synuclein Human genes 0.000 description 4
- 208000029028 brain injury Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 210000002161 motor neuron Anatomy 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 108091006146 Channels Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000283984 Rodentia Species 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 210000000576 arachnoid Anatomy 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000005098 blood-cerebrospinal fluid barrier Anatomy 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 230000000926 neurological effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 2
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 2
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 2
- 102000006378 Catechol O-methyltransferase Human genes 0.000 description 2
- 108020002739 Catechol O-methyltransferase Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 2
- 208000032382 Ischaemic stroke Diseases 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000006386 Myelin Proteins Human genes 0.000 description 2
- 108010083674 Myelin Proteins Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000027137 acute motor axonal neuropathy Diseases 0.000 description 2
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 2
- 230000003172 anti-dna Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000004781 brain capillary Anatomy 0.000 description 2
- 230000006931 brain damage Effects 0.000 description 2
- 231100000874 brain damage Toxicity 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000004656 cell transport Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 210000004289 cerebral ventricle Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000006862 enzymatic digestion Effects 0.000 description 2
- 210000004055 fourth ventricle Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 230000002314 neuroinflammatory effect Effects 0.000 description 2
- 231100000189 neurotoxic Toxicity 0.000 description 2
- 230000002887 neurotoxic effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 210000003200 peritoneal cavity Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000009103 reabsorption Effects 0.000 description 2
- 238000012958 reprocessing Methods 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 210000000211 third ventricle Anatomy 0.000 description 2
- 210000001578 tight junction Anatomy 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 208000016192 Demyelinating disease Diseases 0.000 description 1
- 208000036828 Device occlusion Diseases 0.000 description 1
- 206010064687 Device related infection Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000003870 Drug Overdose Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 201000008450 Intracranial aneurysm Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 206010027202 Meningitis bacterial Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000004264 Osteopontin Human genes 0.000 description 1
- 108010081689 Osteopontin Proteins 0.000 description 1
- 206010033296 Overdoses Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 102000019355 Synuclein Human genes 0.000 description 1
- 108050006783 Synuclein Proteins 0.000 description 1
- 206010043269 Tension headache Diseases 0.000 description 1
- 208000008548 Tension-Type Headache Diseases 0.000 description 1
- 102000000591 Tight Junction Proteins Human genes 0.000 description 1
- 108010002321 Tight Junction Proteins Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 208000022384 autosomal recessive agammaglobulinemia 1 Diseases 0.000 description 1
- 201000009904 bacterial meningitis Diseases 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 208000025698 brain inflammatory disease Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000005112 continuous flow technique Methods 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 206010061811 demyelinating polyneuropathy Diseases 0.000 description 1
- 230000000779 depleting effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 231100000725 drug overdose Toxicity 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- QPJBWNIQKHGLAU-IQZHVAEDSA-N ganglioside GM1 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 QPJBWNIQKHGLAU-IQZHVAEDSA-N 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229960001388 interferon-beta Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003140 lateral ventricle Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000021633 leukocyte mediated immunity Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002025 microglial effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000005264 motor neuron disease Diseases 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000001722 neurochemical effect Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
- 230000001703 neuroimmune Effects 0.000 description 1
- 230000003961 neuronal insult Effects 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000002276 neurotropic effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011422 pharmacological therapy Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004181 riluzole Drugs 0.000 description 1
- 210000000954 sacrococcygeal region Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 206010039722 scoliosis Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 208000005198 spinal stenosis Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000003523 substantia nigra Anatomy 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0007—Epidural catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M2027/004—Implant devices for drainage of body fluids from one part of the body to another with at least a part of the circuit outside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0021—Special media to be introduced, removed or treated removed from and reintroduced into the body, e.g. after treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0464—Cerebrospinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/20—Pathogenic agents
- A61M2202/203—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/20—Pathogenic agents
- A61M2202/206—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0693—Brain, cerebrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1003—Spinal column
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82874506P | 2006-10-09 | 2006-10-09 | |
| PCT/US2007/080834 WO2008105959A2 (en) | 2006-10-09 | 2007-10-09 | Cerebrospinal fluid purification system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014177177A Division JP2014237048A (ja) | 2006-10-09 | 2014-09-01 | 脳脊髄液精製システム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010505556A true JP2010505556A (ja) | 2010-02-25 |
| JP2010505556A5 JP2010505556A5 (enExample) | 2011-11-04 |
Family
ID=39721778
Family Applications (11)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009531646A Withdrawn JP2010505556A (ja) | 2006-10-09 | 2007-10-09 | 脳脊髄液精製システム |
| JP2014177177A Withdrawn JP2014237048A (ja) | 2006-10-09 | 2014-09-01 | 脳脊髄液精製システム |
| JP2016131321A Active JP6492034B2 (ja) | 2006-10-09 | 2016-07-01 | 脳脊髄液精製システム |
| JP2016131320A Active JP6244408B2 (ja) | 2006-10-09 | 2016-07-01 | 脳脊髄液精製システム |
| JP2018142352A Withdrawn JP2018161560A (ja) | 2006-10-09 | 2018-07-30 | 脳脊髄液精製システム |
| JP2019012875A Pending JP2019088849A (ja) | 2006-10-09 | 2019-01-29 | 脳脊髄液精製システム |
| JP2021063570A Active JP7461319B2 (ja) | 2006-10-09 | 2021-04-02 | 脳脊髄液精製システム |
| JP2021153052A Active JP7127196B2 (ja) | 2006-10-09 | 2021-09-21 | 脳脊髄液精製システム |
| JP2022170566A Pending JP2022186892A (ja) | 2006-10-09 | 2022-10-25 | 脳脊髄液精製システム |
| JP2024163950A Pending JP2024173964A (ja) | 2006-10-09 | 2024-09-20 | 脳脊髄液精製システム |
| JP2025091269A Pending JP2025120219A (ja) | 2006-10-09 | 2025-05-30 | 脳脊髄液精製システム |
Family Applications After (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014177177A Withdrawn JP2014237048A (ja) | 2006-10-09 | 2014-09-01 | 脳脊髄液精製システム |
| JP2016131321A Active JP6492034B2 (ja) | 2006-10-09 | 2016-07-01 | 脳脊髄液精製システム |
| JP2016131320A Active JP6244408B2 (ja) | 2006-10-09 | 2016-07-01 | 脳脊髄液精製システム |
| JP2018142352A Withdrawn JP2018161560A (ja) | 2006-10-09 | 2018-07-30 | 脳脊髄液精製システム |
| JP2019012875A Pending JP2019088849A (ja) | 2006-10-09 | 2019-01-29 | 脳脊髄液精製システム |
| JP2021063570A Active JP7461319B2 (ja) | 2006-10-09 | 2021-04-02 | 脳脊髄液精製システム |
| JP2021153052A Active JP7127196B2 (ja) | 2006-10-09 | 2021-09-21 | 脳脊髄液精製システム |
| JP2022170566A Pending JP2022186892A (ja) | 2006-10-09 | 2022-10-25 | 脳脊髄液精製システム |
| JP2024163950A Pending JP2024173964A (ja) | 2006-10-09 | 2024-09-20 | 脳脊髄液精製システム |
| JP2025091269A Pending JP2025120219A (ja) | 2006-10-09 | 2025-05-30 | 脳脊髄液精製システム |
Country Status (5)
| Country | Link |
|---|---|
| US (6) | US8435204B2 (enExample) |
| EP (2) | EP2086573B1 (enExample) |
| JP (11) | JP2010505556A (enExample) |
| ES (2) | ES2981635T3 (enExample) |
| WO (1) | WO2008105959A2 (enExample) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018523524A (ja) * | 2015-08-05 | 2018-08-23 | ミネトロニクス， インコーポレイテッド | 体液から物質を濾過する為の接線流フィルターシステム |
| JP2018529473A (ja) * | 2015-10-06 | 2018-10-11 | ミネトロニクス， インコーポレイテッド | 脳および脊髄に局所冷却を提供する装置および方法 |
| JP2018537191A (ja) * | 2015-12-04 | 2018-12-20 | ミネトロニクス， インコーポレイテッド | 脳脊髄液を処置するためのシステム |
| US10695545B2 (en) | 2006-10-09 | 2020-06-30 | Minnetronix, Inc. | Systems and methods for the conditioning of cerebrospinal fluid |
| JP2020536618A (ja) * | 2017-10-05 | 2020-12-17 | ミネトロニクス， インコーポレイテッド | 中枢神経系に沿って治療を行うためのシステム、カテーテル、及び方法 |
| JP2021513383A (ja) * | 2018-02-14 | 2021-05-27 | フンダシオン・デ・ニューロシエンシアス | 組織または流体から分子を選択的に除去するためのデバイス |
| JP2022526671A (ja) * | 2019-04-11 | 2022-05-25 | エンクリアー セラピーズ， インク． | 脳脊髄液の改善の方法ならびにそのためのデバイスおよびシステム |
| US11529452B2 (en) | 2006-10-09 | 2022-12-20 | Minnetronix, Inc. | Tangential flow filter system for the filtration of materials from biologic fluids |
| JP2023543868A (ja) * | 2020-09-29 | 2023-10-18 | エンクリアー セラピーズ， インク． | くも膜下液管理方法およびシステム |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10850235B2 (en) | 2006-10-09 | 2020-12-01 | Minnetronix, Inc. | Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow |
| US10569064B2 (en) | 2013-03-13 | 2020-02-25 | Minnetronix, Inc. | Devices and methods for providing focal cooling to the brain and spinal cord |
| WO2008105959A2 (en) | 2006-10-09 | 2008-09-04 | Neurofluidics, Inc. | Cerebrospinal fluid purification system |
| EP3199635B1 (en) | 2007-05-11 | 2019-02-06 | Adynxx, Inc. | Gene expression and pain |
| EP4088772A1 (en) * | 2008-01-28 | 2022-11-16 | Implantica Patent Ltd. | A drainage device |
| EP2320987A1 (en) * | 2008-07-29 | 2011-05-18 | Medtronic, Inc. | Apheresis of a target molecule from cerebrospinal fluid |
| WO2010123558A1 (en) * | 2009-04-22 | 2010-10-28 | Neurofluidics, Inc. | Programmable system for conditioning of cerebrospinal fluid |
| CA2763585C (en) | 2009-06-04 | 2017-07-18 | Cardiogard Medical Ltd. | Arterial device, system and method |
| US20110033463A1 (en) * | 2009-08-06 | 2011-02-10 | Medtronic, Inc. | Apheresis, administration of agent, or combination thereof |
| US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
| JP2013032295A (ja) * | 2009-12-04 | 2013-02-14 | Kaneka Corp | タウ蛋白の吸着材および吸着除去システム |
| WO2011114260A1 (en) * | 2010-03-19 | 2011-09-22 | Pfizer Inc. | Cerebrospinal fluid purification system |
| US8303571B2 (en) * | 2010-07-30 | 2012-11-06 | Errorless Medical, Llc | Multiple-line connective devices for infusing medication |
| US20130303971A1 (en) * | 2010-09-10 | 2013-11-14 | Telemetry Research Limited | Catheter and shunt system including the catheter |
| US20120219633A1 (en) * | 2011-02-28 | 2012-08-30 | Pall Corporation | Removal of immunoglobulins and leukocytes from biological fluids |
| US20120311934A1 (en) | 2011-06-07 | 2012-12-13 | Steven Robert Abramson | Draft Guard |
| US10107022B2 (en) | 2011-06-07 | 2018-10-23 | Henniges Automotive Schlegel Canada, Inc. | Draft guard for window assembly having seals and integral fins |
| EP2758780A4 (en) * | 2011-09-22 | 2015-09-16 | Marv Entpr Llc | METHOD OF TREATING MULTIPLE SCLEROSIS |
| CA2872901A1 (en) | 2012-05-10 | 2013-11-14 | Adynxx, Inc. | Formulations for the delivery of active ingredients |
| US20140251925A1 (en) * | 2013-03-11 | 2014-09-11 | Avicure Bioscience, Llc | Bio-fluid treatment device and method |
| US9731122B2 (en) | 2013-04-29 | 2017-08-15 | Rainbow Medical Ltd. | Electroosmotic tissue treatment |
| US20170136221A1 (en) * | 2013-06-17 | 2017-05-18 | Telemetry Research Limited | Catheter and shunt system including the catheter |
| CN103480057A (zh) * | 2013-08-15 | 2014-01-01 | 窦杰 | As-净骨疗法用于治疗强直性脊柱炎的技术及装置 |
| US20150136701A1 (en) * | 2013-11-18 | 2015-05-21 | Arnon Chait | Methods and devices for treating a disease state |
| US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
| CN106687475A (zh) * | 2014-07-10 | 2017-05-17 | 阿费里斯股份公司 | 用于预防和/或治疗亨廷顿氏病的物质和方法 |
| US10272188B1 (en) * | 2014-07-23 | 2019-04-30 | Mensanan Therapeutics LLC | Cerebrospinal fluid treatment |
| CA2957250A1 (en) | 2014-08-15 | 2016-02-18 | Adynxx, Inc. | Oligonucleotide decoys for the treatment of pain |
| US10874798B2 (en) | 2014-10-15 | 2020-12-29 | P&X Medical Nv | Therapeutic applications of artificial cerebrospinal fluid and tools provided therefor |
| US20160287839A1 (en) | 2015-03-31 | 2016-10-06 | Surefire Medical, Inc. | Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment |
| DK3081263T3 (da) * | 2015-04-17 | 2020-03-16 | P&X Medical Nv | Sammensætninger og redskaber til behandling af glaukom |
| US11147540B2 (en) | 2015-07-01 | 2021-10-19 | Minnetronix, Inc. | Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue |
| US9616221B2 (en) | 2015-07-08 | 2017-04-11 | Rainbow Medical Ltd. | Electrical treatment of Alzheimer's disease |
| WO2017053451A1 (en) * | 2015-09-21 | 2017-03-30 | Board Of Regents, The University Of Texas System | Continuous loop drainage system device and method of use |
| US10898716B2 (en) | 2015-10-29 | 2021-01-26 | Rainbow Medical Ltd. | Electrical substance clearance from the brain |
| WO2017117138A1 (en) * | 2015-12-28 | 2017-07-06 | Cognost Therapeutics Inc. | An apparatus and method for cerebral microdialysis to treat neurological disease, including alzheimer's, parkinson's or multiple sclerosis |
| US9770591B2 (en) | 2015-12-29 | 2017-09-26 | Rainbow Medical Ltd. | Disc therapy |
| US11484706B2 (en) | 2015-12-29 | 2022-11-01 | Discure Technologies Ltd | Disc therapy |
| WO2017151644A1 (en) * | 2016-02-29 | 2017-09-08 | Adynxx, Inc. | Compositions and methods for pain amelioration via modification of gene expression |
| US20190151239A1 (en) | 2016-07-28 | 2019-05-23 | Cerebral Therapeutics LLC | Infusing drug solution directly into brain fluid |
| EP3490653B1 (en) | 2016-07-28 | 2025-08-27 | Biogen MA Inc. | Implantable intraventricular sampling and infusion access device |
| US10780250B1 (en) | 2016-09-19 | 2020-09-22 | Surefire Medical, Inc. | System and method for selective pressure-controlled therapeutic delivery |
| US11400263B1 (en) | 2016-09-19 | 2022-08-02 | Trisalus Life Sciences, Inc. | System and method for selective pressure-controlled therapeutic delivery |
| CN114887153A (zh) * | 2016-12-21 | 2022-08-12 | 亚克安娜治疗学有限公司 | 药物递送系统和方法 |
| US10569086B2 (en) | 2017-01-11 | 2020-02-25 | Rainbow Medical Ltd. | Electrical microglial cell activation |
| CA3056201A1 (en) * | 2017-03-17 | 2018-09-20 | Irras Ab | Fluid exchange system and related methods |
| US10588636B2 (en) | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
| US10758722B2 (en) * | 2017-05-03 | 2020-09-01 | Rainbow Medical Ltd. | Electrical treatment of Parkinson's disease |
| ES2694698A1 (es) * | 2017-06-23 | 2018-12-26 | Fundación De Neurociencias | Dispositivo implantable para la eliminación de moléculas tóxicas del líquido cefalorraquídeo |
| US20210052866A1 (en) * | 2017-08-04 | 2021-02-25 | Aethlon Medical, Inc. | Multiplex cerebrospinal fluid processing system |
| WO2019175879A1 (en) | 2018-03-14 | 2019-09-19 | Rainbow Medical Ltd. | Electrical substance clearance from the brain |
| EP3768204A4 (en) | 2018-03-22 | 2022-01-12 | CryoLife, Inc. | DEVICE AND METHOD FOR LOCALIZED HYPOTHERMIA OF THE CENTRAL NERVOUS SYSTEM |
| KR102671857B1 (ko) * | 2018-05-30 | 2024-06-04 | 주식회사 녹십자 | 대뇌 측뇌실 투여에 의해 헌터증후군을 치료하기 위한 방법 및 조성물 |
| AU2019298242B2 (en) | 2018-07-02 | 2022-09-15 | Pharaoh Neuro, Inc. | Systems, catheters, and methods for treating along the central nervous system |
| EP3593833B1 (en) * | 2018-07-13 | 2024-11-06 | Medtronic, Inc. | Catheter for increased intrathecal drug dispersion |
| EP3826650A4 (en) | 2018-07-23 | 2022-07-27 | Enclear Therapies, Inc. | METHODS OF TREATMENT OF NEUROLOGICAL DISEASES |
| EP3826649A4 (en) | 2018-07-23 | 2022-07-20 | Enclear Therapies, Inc. | Methods of treating neurological disorders |
| US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
| EP4574196A3 (en) | 2018-08-08 | 2025-09-03 | Minnetronix Neuro, Inc. | Systems, catheters, and methods for treating along the central nervous system |
| US11338117B2 (en) | 2018-10-08 | 2022-05-24 | Trisalus Life Sciences, Inc. | Implantable dual pathway therapeutic agent delivery port |
| JP2020146311A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146312A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| US12433597B2 (en) | 2019-06-04 | 2025-10-07 | Trisalus Life Sciences, Inc. | Atraumatic occlusive system with compartment for measurement of vascular pressure change |
| CN110496299A (zh) * | 2019-08-14 | 2019-11-26 | 福建医科大学附属第一医院 | 一种用于脑脊液持续净化治疗的双腔导管 |
| US10881858B1 (en) | 2019-09-18 | 2021-01-05 | Rainbow Medical Ltd. | Electrical substance clearance from the brain |
| CN110575573B (zh) * | 2019-09-24 | 2020-12-22 | 福建医科大学附属第一医院 | 一种用于人工脑脊液持续净化治疗的一次性管路安装系统 |
| CN114727878A (zh) * | 2019-09-25 | 2022-07-08 | 黄立臻 | 冷却大脑并诊断和治疗胶质母细胞瘤的装置和方法 |
| US11344714B2 (en) | 2019-11-04 | 2022-05-31 | Medtronic, Inc. | Intrathecal catheter with features to reduce drug dispersion |
| US20230047766A1 (en) * | 2020-02-08 | 2023-02-16 | Sylvian Inc. | Medical device, therapeutic method, and diagnostic methods for the treatment and prevention of vasospasm |
| JP2023062710A (ja) * | 2020-03-27 | 2023-05-09 | テルモ株式会社 | カテーテル |
| CA3183415A1 (en) * | 2020-05-11 | 2021-11-18 | Minnetronix Neuro, Inc. | Filtering cassettes and filtering systems |
| CN116634933A (zh) * | 2020-10-06 | 2023-08-22 | 因柯利尔疗法公司 | 用于控制csf流动和管理颅内压力的系统和方法 |
| EP4278367A1 (en) | 2021-01-15 | 2023-11-22 | Minnetronix Neuro, Inc. | Systems and methods for managing, monitoring, and treating patient conditions |
| US11298530B1 (en) | 2021-05-03 | 2022-04-12 | Discure Technologies Ltd. | Synergistic therapies for intervertebral disc degeneration |
| US11344721B1 (en) | 2021-08-16 | 2022-05-31 | Rainbow Medical Ltd. | Cartilage treatment |
| US11944736B2 (en) | 2022-01-11 | 2024-04-02 | John O. Tate | Methods for treating Alzheimer's disease |
| US11413455B1 (en) | 2022-02-08 | 2022-08-16 | Rainbow Medical Ltd. | Electrical treatment of Alzheimer's disease |
| EP4496603A1 (en) * | 2022-03-22 | 2025-01-29 | Enclear Therapies, Inc. | System and method for managing cancer cells in csf |
| ES3023347A1 (es) * | 2023-11-30 | 2025-05-30 | Neuroscience Innovative Tech S L | Cateter para el transporte de fluidos biologicos y sus solutos |
| US12208267B1 (en) | 2024-04-19 | 2025-01-28 | Yossi Gross | Blood flow enhancement therapy system |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03504681A (ja) * | 1988-04-11 | 1991-10-17 | ディヴェロップメント・コラボレイティヴ・コーポレイション | 身体閉塞を除く装置 |
| JP2001509712A (ja) * | 1997-01-31 | 2001-07-24 | ストーン、アンドリュー | 透析及びショック治療のためのシステム、方法、及び組成物 |
| JP2001513349A (ja) * | 1997-08-08 | 2001-09-04 | ツイン スター メディカル，インコーポレイティド | 部位特定療法のためのシステム及び方法 |
| JP2002514096A (ja) * | 1996-07-11 | 2002-05-14 | シーエスフルイズ，インコーポレイテッド | アルツハイマー型の成人後発症性痴呆を処置する方法および装置 |
| JP2003515394A (ja) * | 1999-12-03 | 2003-05-07 | ニューロン セラポイティックス インコーポレーテッド | 合成脳脊髄液の閉鎖系再循環法および装置 |
| JP2003250881A (ja) * | 2002-01-24 | 2003-09-09 | Codman & Shurtleff Inc | 固有抗サイホン作用式装置 |
| JP2003526398A (ja) * | 1999-03-03 | 2003-09-09 | ユーエイビー リサーチ ファンデーション | 直接中枢神経系カテーテル及び温度制御システム |
| JP2004508109A (ja) * | 2000-09-11 | 2004-03-18 | セエスエフ・ダイナミクス・アクティーゼルスカブ | 脳脊髄液シャント装置および水頭症治療方法 |
Family Cites Families (229)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2969066A (en) | 1956-10-02 | 1961-01-24 | Holter Company | Device for draining ventricular fluid in cases of hydrocephalus |
| US3419010A (en) | 1966-01-17 | 1968-12-31 | Cordis Corp | Catheter |
| US3867937A (en) | 1972-12-07 | 1975-02-25 | Boris Schwartz | Flexible protective sheath for catheter |
| US3889687A (en) | 1974-01-31 | 1975-06-17 | Donald L Harris | Shunt system for the transport of cerebrospinal fluid |
| US4830849A (en) | 1980-04-14 | 1989-05-16 | Thomas Jefferson University | Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
| US4840617A (en) * | 1980-04-14 | 1989-06-20 | Thomas Jefferson University | Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue |
| US4378797A (en) | 1980-04-14 | 1983-04-05 | Thomas Jefferson University | Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
| US4686085A (en) | 1980-04-14 | 1987-08-11 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
| US4446154A (en) | 1982-03-03 | 1984-05-01 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
| US4451251A (en) | 1982-03-03 | 1984-05-29 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
| US4551137A (en) | 1982-10-07 | 1985-11-05 | Cook Incorporated | Flexible sheath assembly for an indwelling catheter |
| US4767409A (en) | 1983-05-23 | 1988-08-30 | Edward Weck Incorporated | Catheter protective shield |
| US4583968A (en) * | 1983-10-03 | 1986-04-22 | Mahurkar Sakharam D | Smooth bore double lumen catheter |
| US4888115A (en) | 1983-12-29 | 1989-12-19 | Cuno, Incorporated | Cross-flow filtration |
| US4958901A (en) | 1987-07-13 | 1990-09-25 | Neurodelivery Technology, Inc. | Method for making a multi-lumen epidural-spinal needle and tip and stock configuration for the same |
| US4950232A (en) | 1987-08-11 | 1990-08-21 | Surelab Superior Research Laboratories | Cerebrospinal fluid shunt system |
| US5948441A (en) | 1988-03-07 | 1999-09-07 | The Liposome Company, Inc. | Method for size separation of particles |
| US4904237A (en) * | 1988-05-16 | 1990-02-27 | Janese Woodrow W | Apparatus for the exchange of cerebrospinal fluid and a method of treating brain and spinal cord injuries |
| US4973312A (en) | 1989-05-26 | 1990-11-27 | Andrew Daniel E | Method and system for inserting spinal catheters |
| EP0478842A1 (de) | 1990-10-05 | 1992-04-08 | PALL BIOMEDIZIN GmbH | Filter zur Filtration menschlicher Cerebronspinalflüssigkeit |
| US5190529A (en) | 1991-05-20 | 1993-03-02 | The Kendall Company | Advancement sleeve and adapter for a catheter |
| US5171226A (en) | 1991-05-20 | 1992-12-15 | The Kendall Company | Method of long term epidural catherization |
| CA2074671A1 (en) | 1991-11-04 | 1993-05-05 | Thomas Bormann | Device and method for separating plasma from a biological fluid |
| US5334315A (en) | 1992-01-17 | 1994-08-02 | Pall Corporation | Priming system |
| US5423738A (en) | 1992-03-13 | 1995-06-13 | Robinson; Thomas C. | Blood pumping and processing system |
| US5396899A (en) | 1993-04-28 | 1995-03-14 | Duke University | Spinal puncture fluid collection apparatus |
| US5364344A (en) * | 1993-10-22 | 1994-11-15 | The Kendall Company | Dual lumen catheter |
| US5405316A (en) | 1993-11-17 | 1995-04-11 | Magram; Gary | Cerebrospinal fluid shunt |
| US6716216B1 (en) | 1998-08-14 | 2004-04-06 | Kyphon Inc. | Systems and methods for treating vertebral bodies |
| IL110288A0 (en) | 1994-07-12 | 1994-10-21 | Bron Dan | Self-cleaning inlet head for a fluid |
| RU2100965C1 (ru) | 1994-08-31 | 1998-01-10 | Научно-исследовательский институт неврологии РАМН | Способ лечения кровоизлияний в мозг и устройство для его осуществления |
| US7069634B1 (en) | 1995-04-28 | 2006-07-04 | Medtronic, Inc. | Method for manufacturing a catheter |
| US5531673A (en) | 1995-05-26 | 1996-07-02 | Helenowski; Tomasz K. | Ventricular catheter |
| US5718692A (en) * | 1995-06-06 | 1998-02-17 | Twineath, L.L.C. | Self-retaining single insertion double catheter assembly and method for making double catheter systems |
| US5772607A (en) | 1995-06-06 | 1998-06-30 | The Nemours Foundation | Body fluid collection apparatus |
| EP0871539B1 (en) | 1995-06-16 | 2002-02-20 | University of Washington | Tangential flow planar microfabricated fluid filter |
| US5683357A (en) | 1995-12-01 | 1997-11-04 | Magram; Gary | External cerebrospinal fluid drain apparatus |
| US5846220A (en) | 1996-04-30 | 1998-12-08 | Medtronic, Inc. | Therapeutic method for treatment of Alzheimer's disease |
| US6383159B1 (en) | 1998-11-10 | 2002-05-07 | Eunoe, Inc. | Devices and method for removing cerebrospinal fluids from a patient's CSF space |
| US20030004495A1 (en) | 1996-07-11 | 2003-01-02 | Eunoe, Inc. | Apparatus and methods for volumetric CSF removal |
| US6689085B1 (en) | 1996-07-11 | 2004-02-10 | Eunoe, Inc. | Method and apparatus for treating adult-onset dementia of the Alzheimer's type |
| EP0824894B1 (en) | 1996-08-16 | 2003-03-12 | Smiths Group PLC | Needle assemblies |
| US5836928A (en) | 1997-02-04 | 1998-11-17 | Gerber; Allen | Spinal fluid collection system |
| US6326044B1 (en) | 1997-06-19 | 2001-12-04 | Tetra Laval Holdings & Finance S.A. | Filter apparatus and method for the production of sterile skimmed milk |
| US5947689A (en) | 1997-05-07 | 1999-09-07 | Scilog, Inc. | Automated, quantitative, system for filtration of liquids having a pump controller |
| US20020197250A1 (en) | 2001-04-10 | 2002-12-26 | Renal Tech International | Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood |
| US20020198487A1 (en) | 2001-04-10 | 2002-12-26 | Renal Tech International | Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids |
| DE20103363U1 (de) | 2001-02-26 | 2001-05-17 | Braun Melsungen Ag | Schutzvorrichtung für eine Injektionsnadel |
| RU2158613C2 (ru) | 1997-08-20 | 2000-11-10 | Иркутский институт усовершенствования врачей | Способ лечения повреждений центральной нервной системы |
| US6066149A (en) | 1997-09-30 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot treatment device with distal filter |
| US6295990B1 (en) | 1998-02-03 | 2001-10-02 | Salient Interventional Systems, Inc. | Methods and systems for treating ischemia |
| US5897528A (en) | 1998-04-30 | 1999-04-27 | Medtronic, Inc. | Filtered intracerebroventricular or intraspinal access port with direct cerebrospinal fluid access |
| EP1083836B1 (en) | 1998-06-01 | 2010-10-13 | Kyphon SÀRL | Expandable preformed structures for deployment in interior body regions |
| US6013051A (en) | 1998-10-22 | 2000-01-11 | Medtronic, Inc. | Filtered access port with filter bypass for accessing body fluid samples |
| US7189221B2 (en) * | 1998-11-10 | 2007-03-13 | Integra Life Sciences Corporation | Methods for the treatment of a normal pressure hydrocephalus |
| US6875192B1 (en) * | 1998-11-10 | 2005-04-05 | Eunoe, Inc. | Devices and methods for removing cerebrospinal fluids from a patient's CSF space |
| US6165199A (en) | 1999-01-12 | 2000-12-26 | Coaxia, Inc. | Medical device for removing thromboembolic material from cerebral arteries and methods of use |
| US6161547A (en) | 1999-01-15 | 2000-12-19 | Coaxia, Inc. | Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use |
| AU2225600A (en) | 1999-01-21 | 2000-08-07 | Thomas M. Kennedy | Sheath, epidural catheter system, and method for inserting catheter |
| DK1154827T3 (da) | 1999-02-22 | 2007-02-19 | Ncsrt Inc | Oprensning af biologiske stoffer |
| US6217552B1 (en) | 1999-03-01 | 2001-04-17 | Coaxia, Inc. | Medical device for selective intrathecal spinal cooling in aortic surgery and spinal trauma |
| US6849185B1 (en) | 1999-05-14 | 2005-02-01 | Pall Corp | Charged membrane |
| US6238382B1 (en) | 1999-08-19 | 2001-05-29 | Datascope Investment Corp. | Intra-aortic balloon catheter having a tapered Y-fitting |
| US6517529B1 (en) * | 1999-11-24 | 2003-02-11 | Radius International Limited Partnership | Hemodialysis catheter |
| WO2001054766A1 (en) | 2000-01-27 | 2001-08-02 | Eunoe, Inc. | Systems and methods for exchanging cerebrospinal fluid |
| US7181289B2 (en) | 2000-03-20 | 2007-02-20 | Pflueger D Russell | Epidural nerve root access catheter and treatment methods |
| US6468219B1 (en) | 2000-04-24 | 2002-10-22 | Philip Chidi Njemanze | Implantable telemetric transcranial doppler device |
| US6447500B1 (en) | 2000-04-28 | 2002-09-10 | Medtronic, Inc. | Brain fluid ion concentration modification for treating neurological disorders |
| EP1289437A1 (en) | 2000-05-31 | 2003-03-12 | Hussain Karim | Epidural apparatus |
| GB2365344A (en) | 2000-08-04 | 2002-02-20 | Alan David Mogg | Catheter adaptor |
| US6497699B1 (en) | 2000-08-09 | 2002-12-24 | The Research Foundation Of State University Of New York | Hybrid neuroprosthesis for the treatment of brain disorders |
| DE10040350A1 (de) * | 2000-08-17 | 2002-03-07 | Rehau Ag & Co | Katheter |
| GR1003723B (el) | 2000-10-19 | 2001-11-19 | Αθανασιου Χρηστος Πανοτοπουλος | Καθετηρας πολλαπλων εφαρμογων |
| US6641563B1 (en) | 2000-11-01 | 2003-11-04 | Arrow International, Inc. | Stylet-free epidural catheter and thread assist device |
| US6602241B2 (en) | 2001-01-17 | 2003-08-05 | Transvascular, Inc. | Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites |
| US6558353B2 (en) | 2001-01-25 | 2003-05-06 | Walter A. Zohmann | Spinal needle |
| US20020193285A1 (en) | 2001-03-02 | 2002-12-19 | Hesson David P. | Neuroprotectants formulations and methods |
| US6689756B2 (en) | 2001-03-02 | 2004-02-10 | Integra Lifesciences Corporation | Treatment of neurological disease |
| WO2002085431A2 (en) | 2001-04-24 | 2002-10-31 | Neuron Therapeutics, Inc. | Method of delivering liquid through cerebral spinal pathway |
| US6699269B2 (en) | 2001-04-30 | 2004-03-02 | Rohit K. Khanna | Selective brain and spinal cord hypothermia method and apparatus |
| US20030028137A1 (en) | 2001-05-18 | 2003-02-06 | Levin Bruce H. | Novel hypothermic modalities and direct application of protective agents to neural structures or into CSF |
| US20030093105A1 (en) | 2001-07-13 | 2003-05-15 | Scimed Life Systems, Inc. | Guide catheter for introduction into the subarachnoid space and methods of use thereof |
| US7455666B2 (en) * | 2001-07-13 | 2008-11-25 | Board Of Regents, The University Of Texas System | Methods and apparatuses for navigating the subarachnoid space |
| US7150737B2 (en) | 2001-07-13 | 2006-12-19 | Sci/Med Life Systems, Inc. | Methods and apparatuses for navigating the subarachnoid space |
| US7011647B2 (en) | 2001-07-13 | 2006-03-14 | Scimed Life Systems, Inc. | Introducer sheath |
| US7025739B2 (en) | 2001-08-09 | 2006-04-11 | Integra Lifesciences Corporation | System and method for treating elevated intracranial pressure |
| WO2003015710A2 (en) | 2001-08-21 | 2003-02-27 | Eunoe, Inc. | Combined drug and csf removal therapies and systems |
| AU2002335658A1 (en) | 2001-08-31 | 2003-03-18 | Neuron Therapeutics, Inc. | Treatment of neurologic hemorrhage |
| US6683066B2 (en) | 2001-09-24 | 2004-01-27 | Yanming Wang | Composition and treatment method for brain and spinal cord injuries |
| AU2002329570A1 (en) | 2001-10-12 | 2003-01-30 | Pfizer Products Inc. | Method of monitoring neuroprotective treatment |
| US20030072761A1 (en) | 2001-10-16 | 2003-04-17 | Lebowitz Jonathan | Methods and compositions for targeting proteins across the blood brain barrier |
| US7308303B2 (en) | 2001-11-01 | 2007-12-11 | Advanced Bionics Corporation | Thrombolysis and chronic anticoagulation therapy |
| US20030163181A1 (en) | 2001-12-07 | 2003-08-28 | Neuron Therapeutics, Inc. | Protection of neurological tissue by direct CNS perfusion cooling |
| US7108680B2 (en) | 2002-03-06 | 2006-09-19 | Codman & Shurtleff, Inc. | Closed-loop drug delivery system |
| WO2003089031A1 (en) | 2002-04-19 | 2003-10-30 | Neuron Therapeutics | Subarachnoid spinal catheter for transporting cerebrospinal fluid |
| US6830561B2 (en) | 2002-05-08 | 2004-12-14 | Scimed Life Systems, Inc. | Catheter with protective sleeve |
| WO2003105942A1 (en) * | 2002-06-14 | 2003-12-24 | Margaret Pamela Richardson | Improvements in and relating to control of liquid flow into or out of a human or animal body |
| HUE031517T2 (en) | 2002-06-19 | 2017-07-28 | Northwest Biotherapeutics Inc | Cross-flow filtration equipment and procedures for leukocyte enrichment |
| DE10228103A1 (de) | 2002-06-24 | 2004-01-15 | Bayer Cropscience Ag | Fungizide Wirkstoffkombinationen |
| US6969383B2 (en) | 2002-09-27 | 2005-11-29 | Medtronic, Inc. | Method for treating severe tinnitus |
| US7632413B2 (en) * | 2002-11-04 | 2009-12-15 | Ashland Licensing And Intellectual Property Llc | Process for treating a liquid medium using ultrasound |
| CA2411569A1 (en) * | 2002-11-12 | 2004-05-12 | Ross E. Mantle | Medical device for the extravascular recirculation of fluid in body cavities at controlled temperature and pressure |
| EP1581285B1 (en) | 2002-12-23 | 2009-02-25 | Medtronic, Inc. | Drug solution density adjustment systems and methods |
| US7004961B2 (en) | 2003-01-09 | 2006-02-28 | Edward Wong | Medical device and method for temperature control and treatment of the brain and spinal cord |
| JP2004236792A (ja) | 2003-02-05 | 2004-08-26 | Toray Ind Inc | 糖尿病合併症因子吸着体 |
| WO2004072647A1 (en) | 2003-02-07 | 2004-08-26 | Beyond Genomics | Removal of proteins from a sample |
| US7267671B2 (en) | 2003-02-07 | 2007-09-11 | Alfred E. Mann Institute For Biomedical Research At The University Of Southern California | Surgical drain with sensors for monitoring fluid lumen |
| US7963956B2 (en) | 2003-04-22 | 2011-06-21 | Antisense Pharma Gmbh | Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique |
| US7241283B2 (en) | 2003-04-25 | 2007-07-10 | Ad-Tech Medical Instrument Corp. | Method for intracranial catheter treatment of brain tissue |
| ATE460194T1 (de) | 2003-05-29 | 2010-03-15 | Renishaw Ireland Ltd | Implantierbare pumpe |
| US20050004504A1 (en) * | 2003-06-24 | 2005-01-06 | Frye Mark R. | Catheter for extracorporeal treatment |
| US7220252B2 (en) | 2003-07-18 | 2007-05-22 | Polyzen, Inc. | Inflatable dual balloon catheter |
| US8340779B2 (en) | 2003-08-29 | 2012-12-25 | Medtronic, Inc. | Percutaneous flat lead introducer |
| US20050085826A1 (en) | 2003-10-21 | 2005-04-21 | Scimed Life Systems, Inc. | Unfolding balloon catheter for proximal embolus protection |
| BRPI0415765A (pt) * | 2003-10-24 | 2006-12-26 | Medtronic Inc | técnicas para tratar desordens neurológicas pela atenuação da produção de mediadores pró-inflamatórios |
| US20050090801A1 (en) | 2003-10-27 | 2005-04-28 | Racz N. S. | Safety spinal catheter |
| US7118549B2 (en) | 2003-10-31 | 2006-10-10 | Codman & Shurtleff, Inc. | Shunt system including a flow control device for controlling the flow of cerebrospinal fluid out of a brain ventricle |
| US7807777B2 (en) | 2003-11-05 | 2010-10-05 | Immuno-Biological Laboratories Co., Ltd. | Marker peptide for alzheimer's disease |
| US7318834B2 (en) | 2004-02-09 | 2008-01-15 | Philip Chidi Njemanze | Apparatus and method for hypothermia and rewarming by altering the temperature of the cerebrospinal fluid in the brain |
| RU2346996C2 (ru) | 2004-06-29 | 2009-02-20 | ЮРОПИЭН НИКЕЛЬ ПиЭлСи | Усовершенствованное выщелачивание основных металлов |
| US20060015160A1 (en) | 2004-07-19 | 2006-01-19 | Seacoast Technologies, Inc. | Method and apparatus for cooling spinal cord and fluid |
| CA2574679C (en) | 2004-07-20 | 2013-06-04 | Medtronic, Inc. | Implantable cerebral spinal fluid drainage device and method of draining cerebral spinal fluid |
| US20060030027A1 (en) * | 2004-08-04 | 2006-02-09 | Aspira Biosystems, Inc. | Capture and removal of biomolecules from body fluids using partial molecular imprints |
| US8366735B2 (en) | 2004-09-10 | 2013-02-05 | Penumbra, Inc. | System and method for treating ischemic stroke |
| CA2486934C (en) * | 2004-11-22 | 2011-07-19 | Jonathan Tyler | Systems for csf drainage |
| WO2006079007A2 (en) | 2005-01-21 | 2006-07-27 | President And Fellows Of Harvard College | Microconcentrator/microfilter |
| US20060175543A1 (en) | 2005-02-08 | 2006-08-10 | John Elefteriades | Intra-thecal catheter and method for cooling the spinal cord |
| US20060224102A1 (en) | 2005-04-05 | 2006-10-05 | Codman & Shurtleff, Inc | Subarachnoid epidural shunt |
| RU2290974C1 (ru) | 2005-04-11 | 2007-01-10 | Ростовский научно-исследовательский онкологический институт МЗ РФ | Способ лечения онкологических больных с метастатическим поражением головного мозга |
| US20060282043A1 (en) | 2005-06-14 | 2006-12-14 | Pyles Stephen T | Intrathecal catheter having a stylet with a curved tip |
| US20120330196A1 (en) | 2005-06-24 | 2012-12-27 | Penumbra Inc. | Methods and Apparatus for Removing Blood Clots and Tissue from the Patient's Head |
| WO2007000020A1 (en) | 2005-06-29 | 2007-01-04 | Compumedics Limited | Sensor assembly with conductive bridge |
| WO2007013945A2 (en) | 2005-07-20 | 2007-02-01 | The Regents Of The University Of California | Treating disorders associated with inflammation |
| US7993821B2 (en) | 2005-08-11 | 2011-08-09 | University Of Washington | Methods and apparatus for the isolation and enrichment of circulating tumor cells |
| GR20050100452A (el) | 2005-09-02 | 2007-04-25 | Estelle Enterprises Limited | Συστημα καθετηρα ανταλλαγης υγρων |
| RU2314838C2 (ru) | 2005-09-19 | 2008-01-20 | ГУ Научный Центр реконструктивной и восстановительной хирургии ВСНЦ СО РАМН (ГУ НЦ РВХ ВСНЦ СО РАМН) | Способ лечения внутримозговых кровоизлияний |
| TWM291018U (en) * | 2005-09-30 | 2006-05-21 | Inventec Corp | Electronic device casing |
| US7850723B1 (en) | 2005-11-28 | 2010-12-14 | Innercool Therapies, Inc. | Method and apparatus for patient temperature control employing titration of therapy using EEG signals |
| US7674240B2 (en) | 2005-12-20 | 2010-03-09 | Abbott Cardiovascular Systems Inc. | Method and apparatus for controlled vessel occlusion |
| GB2436527B (en) | 2006-03-29 | 2008-02-20 | Zsolt Joel Szarka | Needle |
| EP2007506B1 (en) | 2006-03-31 | 2014-03-19 | Danisco US Inc. | Tangential flow filtration apparatuses, systems, and processes for the separation of compounds |
| US20080154181A1 (en) | 2006-05-05 | 2008-06-26 | Khanna Rohit K | Central nervous system ultrasonic drain |
| US20080045883A1 (en) | 2006-08-17 | 2008-02-21 | Milan Radojicic | Devices and methods for monitoring and delivering therapeutics to the spinal cord |
| ES2307396B1 (es) * | 2006-09-14 | 2009-09-30 | Fundacion Para Investigaciones Neurologicas (Fin) | Sistemas de eliminacion de sustancias neurotoxicas causantes de enfermedades neurodegenerativas mediante su atrapamiento selectivo por inmunoafinidad en el liquido cefalo-raquideo circulante. |
| US8231586B2 (en) | 2006-09-15 | 2012-07-31 | Creighton University | Cerebrospinal fluid collection tubes and methods |
| US10632237B2 (en) | 2006-10-09 | 2020-04-28 | Minnetronix, Inc. | Tangential flow filter system for the filtration of materials from biologic fluids |
| US20160051801A1 (en) | 2014-08-19 | 2016-02-25 | Minnetronix, Inc. | Devices and Systems for Access and Navigation of Cerebrospinal Fluid Space |
| US10569064B2 (en) | 2013-03-13 | 2020-02-25 | Minnetronix, Inc. | Devices and methods for providing focal cooling to the brain and spinal cord |
| US10850235B2 (en) | 2006-10-09 | 2020-12-01 | Minnetronix, Inc. | Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow |
| US10695545B2 (en) | 2006-10-09 | 2020-06-30 | Minnetronix, Inc. | Systems and methods for the conditioning of cerebrospinal fluid |
| WO2008105959A2 (en) | 2006-10-09 | 2008-09-04 | Neurofluidics, Inc. | Cerebrospinal fluid purification system |
| US7776003B2 (en) | 2006-10-28 | 2010-08-17 | Alois Zauner | Multimodal catheter for focal brain monitoring and ventriculostomy |
| RU2312678C1 (ru) | 2006-12-12 | 2007-12-20 | Государственное образовательное учреждение дополнительного профессионального образования "Иркутский государственный институт усовершенствования врачей" Федерального агентства по здравоохранению и социальному развитию | Способ экстракорпоральной очистки цереброспинальной жидкости при заболеваниях нервной системы |
| US20080249458A1 (en) | 2007-04-09 | 2008-10-09 | Medtronic Vascular, Inc. | Intraventricular Shunt and Methods of Use Therefor |
| US20080249501A1 (en) | 2007-04-09 | 2008-10-09 | Medtronic Vascular, Inc. | Methods for Simultaneous Injection and Aspiration of Fluids During a Medical Procedure |
| US7967867B2 (en) | 2007-05-31 | 2011-06-28 | Spine Wave, Inc. | Expandable interbody fusion device |
| MX338096B (es) | 2007-06-06 | 2016-04-01 | Héctor De Jesús Velez Rivera | Aguja espinal con una camara para identificar el liquido cefalorraquideo. |
| PL2170181T3 (pl) | 2007-06-22 | 2014-08-29 | Ekos Corp | Sposób i aparat do leczenia wylewów wewnątrzczaszkowych |
| WO2009002849A2 (en) | 2007-06-22 | 2008-12-31 | Millennium Medical Technologies, Inc. | Fluid concentrator, autologous concentrated body fluids, and uses thereof |
| CA2693139C (en) | 2007-07-16 | 2016-08-23 | C.R. Bard, Inc. | Foley catheter having sterile barrier |
| US20140194840A1 (en) | 2007-08-25 | 2014-07-10 | Beckersmith Medical, Inc. | Portable automated body fluid drain control apparatus |
| DK2190497T3 (en) | 2007-08-25 | 2014-03-24 | Beckersmith Medical Inc | APPARATUS FOR AUTOMATED CONTROL OF DRAINAGE OF BODY FLUIDS |
| US8221366B2 (en) | 2007-09-05 | 2012-07-17 | Integra Lifesciences Corporation | Volume limiting bodily fluid drainage system |
| US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
| US8357296B2 (en) | 2007-09-24 | 2013-01-22 | Emd Millipore Corporation | Centrifugal filter |
| US9198687B2 (en) | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
| US7887503B2 (en) | 2007-11-20 | 2011-02-15 | Mark Geiger | Method and apparatus for removing harmful proteins from a mammalian's ventricular cerebrospinal fluid |
| CA2710831A1 (en) | 2007-12-27 | 2009-07-09 | Wilson-Cook Medical, Inc. | Two-part extraction balloon |
| WO2009140202A1 (en) | 2008-05-12 | 2009-11-19 | Cardionephrx, Inc. | Implantable fluid separation system |
| CN100577222C (zh) | 2008-05-22 | 2010-01-06 | 中国人民解放军第三军医大学第三附属医院 | 一种颅内血肿清除后残存有害成分的吸附引流装置 |
| US7799016B2 (en) | 2008-06-20 | 2010-09-21 | Pharmaco-Kinesis Corporation | Magnetic breather pump and a method for treating a brain tumor using the same |
| US8070694B2 (en) | 2008-07-14 | 2011-12-06 | Medtronic Vascular, Inc. | Fiber based medical devices and aspiration catheters |
| EP2320987A1 (en) | 2008-07-29 | 2011-05-18 | Medtronic, Inc. | Apheresis of a target molecule from cerebrospinal fluid |
| WO2010014447A2 (en) | 2008-07-29 | 2010-02-04 | University Of Maryland, Baltimore | Embolectomy stroke device |
| US8163123B2 (en) | 2008-07-31 | 2012-04-24 | Boston Scientific Scimed, Inc. | Bifurcation catheter dual balloon bond and methods |
| US7951110B2 (en) | 2008-11-10 | 2011-05-31 | Onset Medical Corporation | Expandable spinal sheath and method of use |
| US20110029050A1 (en) | 2008-11-18 | 2011-02-03 | John Elefteriades | Intra-ventricular brain cooling catheter |
| US20100168665A1 (en) | 2008-12-30 | 2010-07-01 | Wilson-Cook Medical Inc. | Segmented balloon for catheter tip deflection |
| US9156037B2 (en) | 2009-01-15 | 2015-10-13 | Children's Medical Center Corporation | Microfluidic device and uses thereof |
| US20100204672A1 (en) | 2009-02-12 | 2010-08-12 | Penumra, Inc. | System and method for treating ischemic stroke |
| WO2010123558A1 (en) | 2009-04-22 | 2010-10-28 | Neurofluidics, Inc. | Programmable system for conditioning of cerebrospinal fluid |
| US20100280438A1 (en) | 2009-04-29 | 2010-11-04 | Dr. Jeffrey E. Thomas | Bidirectional cerebral spinal fluid infusion catheter with cooling mechanism and method of use |
| US8905968B2 (en) | 2009-04-29 | 2014-12-09 | Encephalon Technologies, Llc | System for cooling and pressurizing fluid |
| CN102802717A (zh) | 2009-06-19 | 2012-11-28 | 贝尼奇尔股份有限公司 | 用于使鼻腔降温的设备 |
| US8109899B2 (en) * | 2009-07-06 | 2012-02-07 | Likvor Ab | Fully automated method of measuring and regulating cerebrospinal fluid parameters using disposable tube-set |
| CN101653637B (zh) | 2009-08-03 | 2012-05-23 | 方乃成 | 弹头形脑科多孔引流管及采用该引流管的脑科引流装置 |
| US20120296166A1 (en) | 2009-11-13 | 2012-11-22 | Kim Daniel H | Intradural endoscope |
| JP5624629B2 (ja) | 2009-12-23 | 2014-11-12 | サイトベラ，インコーポレイテッド | 粒子を濾過するためのシステム及び方法 |
| US20110190831A1 (en) | 2010-01-29 | 2011-08-04 | Kyphon Sarl | Steerable balloon catheter |
| US20120302938A1 (en) | 2010-03-19 | 2012-11-29 | University Of Washington | Drainage systems for excess body fluids and associated methods |
| WO2011114260A1 (en) | 2010-03-19 | 2011-09-22 | Pfizer Inc. | Cerebrospinal fluid purification system |
| US9662478B2 (en) | 2010-03-19 | 2017-05-30 | University Of Washington | Body fluid drainage system |
| CA2799473C (en) | 2010-05-14 | 2020-03-10 | Todd Sheppard Saunders | Methods and devices for cooling spinal tissue |
| US8894584B2 (en) | 2010-05-28 | 2014-11-25 | Shuntcheck, Inc. | Real time CSF flow measurement system and method |
| IN2013MN00105A (enExample) | 2010-06-13 | 2015-05-29 | Omeq Medical Ltd | |
| US10888657B2 (en) | 2010-08-27 | 2021-01-12 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
| US9211163B1 (en) | 2010-10-26 | 2015-12-15 | Branislav Jaramaz | Apparatus and method for minimally invasive intracranial hematoma evacuation with real-time assessment of clot reduction |
| WO2012099984A1 (en) | 2011-01-18 | 2012-07-26 | Innerspace, Inc. | Stylet that senses csf |
| US20120203290A1 (en) | 2011-02-04 | 2012-08-09 | Interventional Spine, Inc. | Method and apparatus for spinal fixation |
| US9550041B2 (en) | 2011-02-04 | 2017-01-24 | Advanced Pain Center, Llc. | Continuous single wire steerable catheter |
| US9375522B2 (en) | 2011-04-04 | 2016-06-28 | Adnan Iqbal Qureshi | Extradural infusion suction system and method to drain fluid collection in the extradural space of spinal cord |
| CA2841863A1 (en) | 2011-07-25 | 2013-01-31 | Neurosave, Inc. | Non-invasive systems, devices, and methods for selective brain cooling |
| WO2013022796A2 (en) | 2011-08-05 | 2013-02-14 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
| US9402982B2 (en) | 2011-09-05 | 2016-08-02 | Steerable Instruments Bvba | Minimally-advancing luminal catheter |
| US20130066331A1 (en) | 2011-09-14 | 2013-03-14 | Nevro Corporation | Tapered, curved stylets for inserting spinal cord modulation leads and associated systems and methods |
| US9345826B2 (en) | 2011-09-15 | 2016-05-24 | Deka Products Limited Partnership | Recirculating fluid filtration system |
| WO2013052951A2 (en) | 2011-10-07 | 2013-04-11 | The Trustees Of Columbia University In The City Of New York | Fluid component separation devices, methods, and systems |
| CN202409608U (zh) | 2011-11-30 | 2012-09-05 | 卢天喜 | 一次性硬脑膜下置管引流套件 |
| CN104114104B (zh) | 2011-12-08 | 2016-12-07 | 华盛顿大学商业中心 | 超声探针 |
| EP2695633A1 (en) | 2012-08-10 | 2014-02-12 | Irras AB | Fluid exchange catheter |
| EP2695632A1 (en) | 2012-08-10 | 2014-02-12 | Irras AB | Fluid exchange catheter and process for unblocking a fluid exchange catheter |
| US10786784B2 (en) | 2012-09-06 | 2020-09-29 | Smartflow Technologies, Inc. | Permeate channel alterations for counter current filtration for use in cross-flow filtration modules useful in osmotic systems |
| US10159782B2 (en) | 2012-09-19 | 2018-12-25 | University Of Virginia Patent Foundation | Method and system for enhanced imaging visualization of deep brain anatomy using infusion |
| CN102973305B (zh) | 2012-11-20 | 2016-03-02 | 中国人民解放军第三军医大学第一附属医院 | 一种颅内出血早期血肿微创清除系统 |
| US8721642B1 (en) | 2013-01-28 | 2014-05-13 | Neuraxis, Llc | Tissue cooling clamps and related methods |
| WO2014160481A1 (en) | 2013-03-13 | 2014-10-02 | Beckersmith Medical, Inc. | Portable automated body fluid drain control apparatus |
| WO2014160469A1 (en) | 2013-03-13 | 2014-10-02 | Beckersmith Medical, Inc. | Fluid drain tube with connector |
| WO2014160395A1 (en) | 2013-03-13 | 2014-10-02 | Beckersmith Medical, Inc. | Fluid drain tube with tissue oxygenation content sensor |
| CN105307564A (zh) | 2013-04-23 | 2016-02-03 | 桑贾伊·德豪 | 脑脊液冷却装置 |
| ES2723962T3 (es) | 2014-01-08 | 2019-09-04 | A V Medical Tech Ltd | Dispositivos para la toma de imágenes y el tratamiento de vasos sanguíneos |
| EP3094242A4 (en) | 2014-01-16 | 2018-03-14 | University Of Washington Through Its Center For Commercialization | Pressure reference assemblies for body fluid drainage systems and associated methods |
| US10548630B2 (en) | 2014-02-11 | 2020-02-04 | Vanderbilt University | System, method, and apparatus for configuration, design, and operation of an active cannula robot |
| CN203816046U (zh) | 2014-03-25 | 2014-09-10 | 吴婷 | 颅内血肿穿刺引流套管 |
| US20170209056A1 (en) | 2014-04-07 | 2017-07-27 | University Of Washington | Implantable self-calibrating sensor assemblies and associated methods |
| CN203935243U (zh) | 2014-07-03 | 2014-11-12 | 任宝龙 | 颅脑微创穿刺引流装置 |
| WO2016007553A1 (en) | 2014-07-08 | 2016-01-14 | The Regents Of The University Of California | Image-guided irrigating suction cannula for removal of intracerebral hemorrhage and other lesions |
| EP3212275B1 (en) | 2014-10-31 | 2020-08-05 | Cerevasc, LLC | System for treating hydrocephalus |
| US10258354B2 (en) | 2014-12-22 | 2019-04-16 | Cognition Medical Corp | Post-conditioning suction catheter apparatus and methods |
| US11147540B2 (en) | 2015-07-01 | 2021-10-19 | Minnetronix, Inc. | Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue |
-
2007
- 2007-10-09 WO PCT/US2007/080834 patent/WO2008105959A2/en not_active Ceased
- 2007-10-09 ES ES20209307T patent/ES2981635T3/es active Active
- 2007-10-09 JP JP2009531646A patent/JP2010505556A/ja not_active Withdrawn
- 2007-10-09 US US12/444,581 patent/US8435204B2/en active Active
- 2007-10-09 EP EP07873762.4A patent/EP2086573B1/en active Active
- 2007-10-09 ES ES07873762T patent/ES2845146T3/es active Active
- 2007-10-09 EP EP20209307.6A patent/EP3827841B1/en active Active
-
2013
- 2013-03-13 US US13/801,215 patent/US9895518B2/en active Active
-
2014
- 2014-09-01 JP JP2014177177A patent/JP2014237048A/ja not_active Withdrawn
-
2016
- 2016-07-01 JP JP2016131321A patent/JP6492034B2/ja active Active
- 2016-07-01 JP JP2016131320A patent/JP6244408B2/ja active Active
-
2017
- 2017-01-19 US US15/410,219 patent/US10398884B2/en active Active
-
2018
- 2018-07-30 JP JP2018142352A patent/JP2018161560A/ja not_active Withdrawn
-
2019
- 2019-01-29 JP JP2019012875A patent/JP2019088849A/ja active Pending
- 2019-08-22 US US16/548,554 patent/US11065425B2/en active Active
-
2021
- 2021-04-02 JP JP2021063570A patent/JP7461319B2/ja active Active
- 2021-06-22 US US17/354,388 patent/US12280229B2/en active Active
- 2021-06-22 US US17/354,429 patent/US20210386982A1/en active Pending
- 2021-09-21 JP JP2021153052A patent/JP7127196B2/ja active Active
-
2022
- 2022-10-25 JP JP2022170566A patent/JP2022186892A/ja active Pending
-
2024
- 2024-09-20 JP JP2024163950A patent/JP2024173964A/ja active Pending
-
2025
- 2025-05-30 JP JP2025091269A patent/JP2025120219A/ja active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03504681A (ja) * | 1988-04-11 | 1991-10-17 | ディヴェロップメント・コラボレイティヴ・コーポレイション | 身体閉塞を除く装置 |
| JP2002514096A (ja) * | 1996-07-11 | 2002-05-14 | シーエスフルイズ，インコーポレイテッド | アルツハイマー型の成人後発症性痴呆を処置する方法および装置 |
| JP2001509712A (ja) * | 1997-01-31 | 2001-07-24 | ストーン、アンドリュー | 透析及びショック治療のためのシステム、方法、及び組成物 |
| JP2001513349A (ja) * | 1997-08-08 | 2001-09-04 | ツイン スター メディカル，インコーポレイティド | 部位特定療法のためのシステム及び方法 |
| JP2003526398A (ja) * | 1999-03-03 | 2003-09-09 | ユーエイビー リサーチ ファンデーション | 直接中枢神経系カテーテル及び温度制御システム |
| JP2003515394A (ja) * | 1999-12-03 | 2003-05-07 | ニューロン セラポイティックス インコーポレーテッド | 合成脳脊髄液の閉鎖系再循環法および装置 |
| JP2004508109A (ja) * | 2000-09-11 | 2004-03-18 | セエスエフ・ダイナミクス・アクティーゼルスカブ | 脳脊髄液シャント装置および水頭症治療方法 |
| JP2003250881A (ja) * | 2002-01-24 | 2003-09-09 | Codman & Shurtleff Inc | 固有抗サイホン作用式装置 |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11529452B2 (en) | 2006-10-09 | 2022-12-20 | Minnetronix, Inc. | Tangential flow filter system for the filtration of materials from biologic fluids |
| US10695545B2 (en) | 2006-10-09 | 2020-06-30 | Minnetronix, Inc. | Systems and methods for the conditioning of cerebrospinal fluid |
| JP2018523524A (ja) * | 2015-08-05 | 2018-08-23 | ミネトロニクス， インコーポレイテッド | 体液から物質を濾過する為の接線流フィルターシステム |
| US12364952B2 (en) | 2015-08-05 | 2025-07-22 | Minnetronix, Inc. | Tangential flow filter system for the filtration of materials from biologic fluids |
| US12290785B2 (en) | 2015-08-05 | 2025-05-06 | Minnetronix, Inc. | Tangential flow filter system for the filtration of materials from biologic fluids |
| JP7166915B2 (ja) | 2015-08-05 | 2022-11-08 | ミネトロニクス， インコーポレイテッド | 体液から物質を濾過する為の接線流フィルターシステム |
| JP2020171791A (ja) * | 2015-10-06 | 2020-10-22 | ミネトロニクス， インコーポレイテッド | 脳および脊髄に局所冷却を提供するシステム |
| JP2018529473A (ja) * | 2015-10-06 | 2018-10-11 | ミネトロニクス， インコーポレイテッド | 脳および脊髄に局所冷却を提供する装置および方法 |
| US11577060B2 (en) | 2015-12-04 | 2023-02-14 | Minnetronix, Inc. | Systems and methods for the conditioning of cerebrospinal fluid |
| JP2018537191A (ja) * | 2015-12-04 | 2018-12-20 | ミネトロニクス， インコーポレイテッド | 脳脊髄液を処置するためのシステム |
| JP2020536618A (ja) * | 2017-10-05 | 2020-12-17 | ミネトロニクス， インコーポレイテッド | 中枢神経系に沿って治療を行うためのシステム、カテーテル、及び方法 |
| JP2021513383A (ja) * | 2018-02-14 | 2021-05-27 | フンダシオン・デ・ニューロシエンシアス | 組織または流体から分子を選択的に除去するためのデバイス |
| JP7255899B2 (ja) | 2018-02-14 | 2023-04-11 | フンダシオン・デ・ニューロシエンシアス | 組織または流体から分子を選択的に除去するためのデバイス |
| JP2022526671A (ja) * | 2019-04-11 | 2022-05-25 | エンクリアー セラピーズ， インク． | 脳脊髄液の改善の方法ならびにそのためのデバイスおよびシステム |
| JP2023543868A (ja) * | 2020-09-29 | 2023-10-18 | エンクリアー セラピーズ， インク． | くも膜下液管理方法およびシステム |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7127196B2 (ja) | 脳脊髄液精製システム | |
| WO2011114260A1 (en) | Cerebrospinal fluid purification system | |
| JP7408730B2 (ja) | 中枢神経系に沿って治療するためのシステム、カテーテル、および方法 | |
| JP2022526671A (ja) | 脳脊髄液の改善の方法ならびにそのためのデバイスおよびシステム | |
| JP2022186954A (ja) | 中枢神経系に沿って治療を行うためのシステム、カテーテル、及び方法 | |
| US20230321412A1 (en) | System and method for managing cancer cells in csf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101007 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101007 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110905 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120824 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120906 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121205 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121212 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130104 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130111 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130205 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130213 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130305 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130805 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131031 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131108 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131203 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131210 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131226 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140109 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140204 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140430 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140901 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140930 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20141023 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20141128 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151124 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20160428 |